Inherited deficiency of antithrombin III in an Italian kindred

Armando Tripodi, Catherine Boyer, Maria Teresa Canciani, Armando D'Angelo, Pier Mannuccio Mannucci

Research output: Contribution to journalArticlepeer-review


Life-long symptoms of venous thromboembolism were present throughout five generations in a large Italian kindred. Eight out of the 22 tested members of the family had reduced plasma levels of antithrombin III (AT III), the main physiological inhibitor of blood coagulation. Three of them, aged 2-28 years, had no thrombotic manifestations. AT III deficiency, which was hitherto thought to be very rare in this country, appeared to be related to a reduced synthesis of the protein without any qualitative abnormality. This view is supported by the concomitant reduction of AT III levels as demonstrated by biological and immunological assays, as well as by a normal pattern of the protein in double-crossed immunoelectrophoresis with and without heparin added to the agarose gel. Long-term treatment with oral anticoagulants appeared to prevent further thromboembolic episodes in two patients, even though plasma AT III levels remained unchanged.

Original languageEnglish
Pages (from-to)521-531
Number of pages11
JournalLa Ricerca in Clinica e in Laboratorio
Issue number3
Publication statusPublished - Jul 1980


  • Antithrombin III deficiency
  • Thrombophilia
  • Venous thromboembolism

ASJC Scopus subject areas

  • Clinical Biochemistry


Dive into the research topics of 'Inherited deficiency of antithrombin III in an Italian kindred'. Together they form a unique fingerprint.

Cite this